Key Findings
The Europe non-PVC IV bags market is predicted to project a CAGR of 7.50% during the forecast period, 2021-2028. The rising awareness regarding the use of non-PVC IV bags and government initiatives & concerns regarding patient health and safety propel market growth.

Market Insights
The United Kingdom, Poland, France, Germany, Russia, Italy, Belgium, and Rest of Europe are evaluated for the analysis of the Europe non-PVC IV bags market growth. Germany has a top-class healthcare infrastructure in comparison to other European countries. Also, the German Federal Institute for Drugs and Medical Devices recommends the use of alternatives to PVC-based medical devices. As a result, manufacturers are striving to develop safer alternatives to PVC-based products. Additionally, they are to inform about the risks of phthalate exposure through PVC products. Moreover, there is a prohibition on the use of PVC-based products for neonatal care. Furthermore, several environmental committees prioritize non-PVC alternatives, given their benefits like reduced environmental threats and minimized recycling costs.
In countries like Italy, malnutrition is prevalent in the elderly population. Around 622 deaths were recorded in the country, as per the 2018 WHO data. Among the geriatric population, malnutrition is attributed to financial constraints, oral health problems, polypharmacy, gastrointestinal problems, decreased sensory functions, etc. It is also linked to the difficulty of obtaining food, impaired digestion, and poor appetite. Additionally, as per 2021 stats, Italy had the largest percentage of the senior population (aged 6 and above) in 2019. Such factors contribute to the market growth in Italy.

Competitive Insights
Some of the key companies in the market are Fresenius Kabi, Huaren Pharmaceutical, Baxter International Inc, ICU Medical, JW Life Science, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments